Company / Book Value per Share
Lexaria Bioscience Corp. Book Value per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.189
FY2025
5-year range
$0.189 / $2.316
FY2021-FY2025
Trend
-81.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 10 years, ranging from $0.006 in FY2016 to $2.316 in FY2022.
Based on SEC 10-K filings.
$0.189 in FY2025 with a 10-year CAGR of +23.7%.
Declined from $0.512 to $0.189 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -56.6%
- 5-Year CAGR
- +44.3%
- 10-Year CAGR
- +23.7%
Key checks
Key Insights
- 5-year CAGR of +44.3%, indicating consistent growth.
- In FY2025, book value per share decreased 81.0% year-over-year.
- Peak book value per share was recorded in FY2022.
- Lowest book value per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.189 | -81.0% |
| FY2024 | $0.993 | +94.2% |
| FY2023 | $0.512 | -77.9% |
| FY2022 | $2.316 | +180.1% |
| FY2021 | $0.827 | +2634.2% |
| FY2020 | $0.03 | -17.5% |
| FY2019 | $0.037 | -37.5% |
| FY2017 | $0.059 | +865.9% |
| FY2016 | $0.006 | -73.1% |
| FY2015 | $0.023 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026